Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years

By sjmartinez • January 6, 2024

Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, Vencovský J, Wilson AG, Burmester GR, Coombs D, Penn SK, Khan N, Yee JB, Rahawi K, McInnes IB. Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatol Ther. 2024 Jan 5. doi: 10.1007/s40744-023-00624-3. Epub ahead of print. PMID: 38180720.

Tags: JAK inhibitor, Laboratory parameters, Publications, Rheumatoid arthritis, Rheumatology, Upadacitinib

Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement

Whitley MJ, Wang JX, Chapman J, de Vries APJ, Chandran S, Glennon CM, Madariaga HM, Carroll RP, Booth J, Concepcion B, Couzi L, De Serres[...]

A normal BNP does not reliably exclude pulmonary hypertension in interstitial lung disease

Brownstein AJ, Lliang L, Channick R, Kim A, Saggar R. A normal BNP does not reliably exclude pulmonary hypertension in interstitial lung disease. Eur Respir[...]

Indefinite for dysplasia in Barrett’s esophagus: definitely worth your attention

Muthusamy VR. Indefinite for dysplasia in Barrett's esophagus: definitely worth your attention. Gastrointest Endosc. 2026 Jan;103(1):84-86. doi: 10.1016/j.gie.2025.06.024. PMID: 41412705.